or Try an Advanced Search...

    Enzyme Replacement Therapies Stocks List

    Symbol Grade Name % Change
    SNY B Sanofi -0.94
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major
    Related Stock Lists: Animal Health Cac 40 Cancer Chronic Kidney Disease Clopidogrel Colorectal Cancer Consumer Health Care Consumer Health Care Products Deep Vein Thrombosis Dialysis Fever Gaucher Disease Glucose Glucose Meter Health Care Products Health Sciences Healthcare Products Hepatotoxins Hypertension Influenza

    Related ETFs - A few ETFs which own one or more of the above listed Enzyme Replacement Therapies stocks.

    Symbol Grade Name Weight
    PPH B Market Vectors Pharmaceutical ETF 4.57
    VIRS C Pacer BioThreat Strategy ETF 4.22
    MEDI D Harbor Health Care ETF 2.83
    PID A PowerShares Intl Dividend Achievers 2.81
    PVAL A Putnam Focused Large Cap Value ETF 2.27
    View all Enzyme Replacement Therapies ETFs...
    Compare ETFs
    Compare PPH to PID Compare PPH to VIRS Compare VIRS to MEDI

        Enzyme Replacement Therapies Stocks Recent News

        Date Stock Title
        May 24 SNY Zantac Verdict: Jury Finds No Link To Colon Cancer In Initial Trial, GSK And Boehringer Prevail In First Zantac Cancer Lawsuit
        May 23 SNY Sanofi reports positive data from Phase II asthma treatment trial
        May 22 SNY Sanofi says asthma candidate rilzabrutinib buoyed by phase 2 results
        May 22 SNY Bristol-Myers, Sanofi liability in Hawaii Plavix litigation tops $900M
        May 22 SNY Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M
        May 22 SNY First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
        May 22 SNY Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million
        May 22 SNY Better Buy: Inovio Pharmaceuticals vs. Novavax
        May 22 SNY 3 Things You Need to Know If You Buy Novavax Today
        May 22 SNY Sanofi enters partnership to enhance drug development using AI
        May 22 SNY Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit
        May 21 SNY Sanofi (SNY) Signs Deal for AI-Powered Drug Development
        May 21 SNY ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development
        May 21 SNY Sanofi teams up with Formation Bio, OpenAI on AI-driven drug development
        May 21 SNY Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
        May 20 SNY Sanofi: Information concerning the total number of voting rights and shares - April 2024
        May 20 SNY Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM
        May 20 SNY Shah Capital ends campaign against Novavax board after Sanofi deal
        May 19 SNY This Stock Just More Than Doubled in 1 Day: Is It a Buy?
        May 18 SNY Is Novavax Stock a Buy?
        Related Industries: Drug Manufacturers - Major
        Related Stock Lists: Animal Health Cac 40 Cancer Chronic Kidney Disease Clopidogrel Colorectal Cancer Consumer Health Care Consumer Health Care Products Deep Vein Thrombosis Dialysis Fever Gaucher Disease Glucose Glucose Meter Health Care Products Health Sciences Healthcare Products Hepatotoxins Hypertension Influenza
        Enzyme Replacement Therapies

        Enzyme Replacement Therapies (ERT) is a type of treatment used to treat certain genetic diseases caused by a lack of specific enzymes in the body. This type of therapy involves replacing the missing enzyme with a synthetic version, which can help restore normal functioning of the body. ERT is used to treat diseases such as Gaucher disease, Fabry disease, and Pompe disease.

        Browse All Tags